Join a Study for Steatohepatitis (MASH) (Scottsdale)

Join the Fight Against Steatohepatitis (MASH)! Metabolically dysfunction-associated steatohepatitis (MASH) is a progressive form of fatty liver disease. It occurs when fat builds up in the liver (a condition known as steatosis) and is accompanied by inflammation and liver cell damage. This condition is part of a broader spectrum of liver diseases linked to metabolic dysfunction, including obesity, type 2 diabetes, high cholesterol, and insulin resistance. MASH was previously referred to as nonalcoholic steatohepatitis (NASH) but has recently been renamed to better reflect its association with metabolic health rather than alcohol use. We’re looking for patient volunteers to help assess the effectiveness of a new medication for this condition. The medication is provided at no cost to you or your insurance, and you will be compensated for your time and travel. Plus, if you refer a friend who qualifies, you can earn a $100 BONUS! Don’t miss this opportunity! Call 480-382-7909 Now! Or Apply Here To qualify, you must be: ● Must be 18 years or older ● Diagnosed with a liver condition called MASH Why Participate? ● Compensation: Get compensated up to $100 per clinic visit with no cost to you or your insurance! ● Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being. ● Free study medications: Study medication for Steatohepatitis (MASH) is provided at no cost. Check out our other studies! ● Psychosis associated with Alzheimer’s disease ● Active Psoriatic Arthritis ● Cirrhosis ● Diabetic Peripheral Neuropathy Pain ● Osteoarthritis of the Knee ● Plantar Fibromatosis (PFI) - Ledderhose Disease ● Prurigo Nodularis ● Future Studies Scottsdale Clinical Trials Get Involved Today! Your participation can help advance research and improve lives. If you're ready to take action, contact us at 480-382-7909 or visit the Scottsdale Clinical Trials website for more information.